INS and sarcopenia: In most studies evaluating the association between different glucose-lowering drugs and the prevalence of sarcopenia the majority of the participants were on at least two medications; the most frequently used were biguanides (metformin), dipeptidyl dipeptidase 4 inhibitors, sulfonylureas, and insulin (Table 3).